2 withdrawn. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Withdrawn 2 |
Follow Thinness: new trials by email Literature Review of Thinness trials Research Report on Thinness
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Cannabis in Pancreatic Cancer THC and CBD Mixture - Neoplasms Pancreatic, Cachexia; Cancer | Phase 2 | Withdrawn | Jens Rikardt Andersen | 2017-10-06 | 2023-12-18 | |
| Study of Muscle Effects of BYM338 in Mechanically Ventilated Patients BYM338, Placebo - Mechanical Ventilation | Phase 2 | Withdrawn | Novartis Pharmaceuticals | 2014-04-01 | 2015-01-07 |
Cachexia (2) · Anorexia (1) · Marijuana Abuse (1) · Neoplasms (1) · Pancreatic Neoplasms (1) · Respiratory Insufficiency (1)
Body Weight (2) · Body Weight Changes (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Weight Loss (2) · Chemically-Induced Disorders (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Mental Disorders (1) · Neoplasms by Site (1) · Pancreatic Diseases (1) · Respiration Disorders (1)
bimagrumab (1) · nabiximols (1)
Jens Rikardt Andersen (1) · Novartis Pharmaceuticals (1)
Denmark (1)
Jens Rikardt Andersen, MD, MPA (1)
PMID 12648025, PMID 16317825, PMID 17566383, PMID 18728826, PMID 19587829, PMID 19883531, PMID 19896326, PMID 20076976, PMID 22076835, PMID 23141881, PMID 26883879, PMID 27403414